InvestorsHub Logo
Followers 24
Posts 2696
Boards Moderated 0
Alias Born 04/21/2012

Re: None

Wednesday, 02/06/2013 10:06:39 AM

Wednesday, February 06, 2013 10:06:39 AM

Post# of 130507
"Additionally, Amarantus has recently announced the acquisition of Neurodegenerative
Diagnostic’s intellectual property portfolio, which includes diagnostics for PD and ALS – further
positioning the company as an emerging player in the field of neurological disorders." !!!!